ask="1.36"
ask_size="100"
average_daily_volume="92976"
bid="1.10"
bid_size="600"
book_value="0.69"
change="-0.04"
change_from_200_day_moving_average="-0.15"
change_from_50_day_moving_average="0.16"
change_from_52_week_high="-6.61"
change_From_52_week_low="0.42"
change_in_percent="-2.90%"
close="1.34"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.16"
ebitda="-17.60M"
eps_estimate_current_year="-1.09"
eps_estimate_next_quarter="-0.29"
eps_estimate_next_year="-0.82"
ex_dividend_date="N/A"
float_shares="6119000"
high="1.43"
high_52_weeks="7.95"
last_trade_date="2/6/2017"
last_trade_price="1.34"
last_trade_size="100"
last_trade_time="4:00pm"
low="1.26"
low_52_weeks="0.92"
market_capitalization="21.96M"
moving_average_200_day="1.49"
moving_average_50_day="1.18"
name="Bioblast Pharma Ltd."
notes="N/A"
one_year_target_price="9.00"
open="1.40"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-10.20%"
percent_change_from_50_day_moving_average="+13.61%"
percent_change_from_52_week_high="-83.14%"
percent_change_from_52_week_low="+45.65%"
previous_close="1.38"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.99"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="16391000"
short_ratio="2.68"
stock_exchange="NGM"
symbol="ORPN"
volume="74382"
weeks_range_52="0.92 - 7.95"
